Home/Filings/4/0001193805-22-001614
4//SEC Filing

Payne Joseph E 4

Accession 0001193805-22-001614

CIK 0001768224other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 4:07 PM ET

Size

4.8 KB

Accession

0001193805-22-001614

Insider Transaction Report

Form 4
Period: 2022-11-23
Payne Joseph E
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2022-11-23$16.51/sh+5,000$82,5501,480,097 total
Footnotes (1)
  • [F1]Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction.

Issuer

Arcturus Therapeutics Holdings Inc.

CIK 0001768224

Entity typeother

Related Parties

1
  • filerCIK 0001727315

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:07 PM ET
Size
4.8 KB